T-Mobile US, Inc. 8-K Filing: Debt Instruments & Stock Insights - February 2025

$TMUS
Form 8-K
Filed on: 2025-02-21
Source
T-Mobile US, Inc. 8-K Filing: Debt Instruments & Stock Insights - February 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company: T-Mobile US, Inc.
  • SEC CIK Identifier: 0001283699
  • Address: 12920 SE 38th Street, Bellevue, WA 98006-1350
  • Phone: 425-378-4000
  • Registration Type: 8-K filing
  1. Stock Information:
  • Common Stock Par Value: $0.00001 per share
  • Trading Symbol: TMUS (NASDAQ)
  1. Debt Instruments:
  • The report includes details on several series of Senior Notes, each with specific interest rates and maturity dates:
    • 3.550% Senior Notes due 2029
    • 3.700% Senior Notes due 2032
    • 3.150% Senior Notes due 2032 (note: this series appears to have a typo in the report as it lists the same year as the previous note)
    • 3.850% Senior Notes due 2036
    • 3.500% Senior Notes due 2037
    • 3.800% Senior Notes due 2045
  1. Filing Context:
  • The report covers a specific context period from February 18, 2025, to February 18, 2025, indicating a specific date of significance for reporting.
  1. Identifiers for Notes:
  • Various identifiers are used for each series of Senior Notes which would be useful for investors tracking the performance and details of each bond.

Insights:

  • The company has multiple debt instruments with varying maturities and interest rates, which indicates an active approach to managing its capital structure and financing needs.
  • The presence of low par value stock suggests a strategy that may allow for flexibility in issuing more shares without significant dilution.
  • This filing appears to be part of a routine update under SEC regulations, which provides transparency to investors regarding T-Mobile's financial obligations.

Overall, this report provides a snapshot of T-Mobile's equity and debt situation as of February 2025, which is essential for investors and analysts monitoring the company's financial health and capital management.